Abstract :
To fundamentally resolve the inherent limitations of conventional marine fish (salmon and trout)-derived polydeoxyribonucleotide (PDRN)—specifically residual animal protein allergenicity, intense fishy odor leading to behavioral aversion upon oral licking or topical application in companion animals (aversion rate: 47.5%), and marine heavy metal bioaccumulation risks—this study investigated the pharmaceutical optimization, cellular molecular mechanisms, and preclinical efficacy and safety of a topical mist formulation specifically designed for companion animals (canine and feline). The formulation combines highly purified Phyto-PDRN derived from Aloe vera adventitious roots and Centella asiatica (Cica-PDRN; Sodium DNA, 50–1,500 bp) with dexpanthenol (1.0–1.5%), a pivotal epidermal barrier-repair agent, classified as an animal quasi-drug external topical liquid. Unlike human skin, companion animals possess a fragile stratum corneum composed of merely 3–5 cell layers and maintain a neutral to weakly alkaline epidermal surface pH (canine pH 6.2–7.5; feline pH 6.0–7.2). Accordingly, the final formulation was precisely buffered to pH 6.8–7.2. In an oil-free, water-based aerosol system, the severe nozzle-clogging issue associated with poorly soluble ceramide NP (0.05%) was completely resolved via a liquid nano-solubilization premix technology. Regarding antimicrobial preservation, six harmful synthetic preservatives (including parabens and phenoxyethanol) were entirely excluded; instead, an EWG Grade 1 natural multi-preservative booster system consisting of 1,2-hexanediol (1.0%), sodium phytate (0.05%), and ethylhexylglycerin (0.05%) was established, satisfying USP <51> antimicrobial effectiveness criteria and validating a 24-month shelf-life stability (via 6-month accelerated testing at 40°C/75% RH). In vitro bioactivity evaluations demonstrated that the Aloe and Centella PDRN complex exhibited an outstanding DPPH free radical scavenging activity of 96.0%. In human epidermal keratinocytes (HaCaT) and dermal fibroblasts (HDF), the complex markedly upregulated the gene expressions of antioxidant enzyme SOD1 (135.2%), epidermal barrier structural proteins filaggrin (FLG, 128.4%) and loricrin (LOR, 132.8%), and type I collagen (COL1A1, 142.1%), while potently suppressing matrix metalloproteinase-1 (MMP-1) expression to 48.3%. In particular, selective purinergic adenosine A2A receptor (A2AR) activation accelerated fibroblast proliferation by 215.4% (which was abrogated to 112.1% by the selective A2AR antagonist ZM241385, verifying the specific molecular mechanism) and promoted 94.8% scratch wound closure within 24 h. In cellular and animal preclinical models, the formulation protected feline renal epithelial cells (CRFK) against severe oxidative cytopathy, restoring cell viability to 94.1% and decreasing TUNEL-positive apoptotic cells to 8.2%. In BALB/c mice with full-thickness cutaneous excision wounds, the mist complex induced 96.8% re-epithelialization on day 14 alongside robust neo-capillary CD31 angiogenesis and dense collagen remodeling. Moreover, the formulation demonstrated zero mucosal ocular irritation in the chorioallantoic membrane (HET-CAM score 0.0) and achieved exceptional palatability and acceptance rates (90.0–93.3%) in dogs and cats. Consequently, this study successfully establishes the scientific foundation for an oral-safe, 100% vegan animal quasi-drug mist formulation and validates its commercialization and contract development and manufacturing organization (CDMO) viability.
Keywords :
Adenosine A2A Receptor (A2AR), Aloe vera PDRN, Animal Quasi-Drug, Centella asiatica PDRN, Dexpanthenol, Epidermal Barrier Restoration, Oral Biocompatibility, Veterinary Mist FormulationReferences :
- Altavilla, D., Bitto, A., Polito, F., Irrera, N., Cattarini, G., & Squadrito, F. (2017). Pharmacological activity and clinical use of PDRN. Frontiers in Pharmacology, 8, 224. https://doi.org/10.3389/fphar.2017.00224
- Kim, D. M., Lee, J. K., Lee, W. K., Moon, H. A., Cho, Y. J., Bae, J. Y., Kim, J. W., & Choi, Y. M. (2026). Protective Effects of Plant-Derived PDRN and Phytochemical Complex from Rubus buergeri Miquel on Pet Renal Cells, Patellar Osteoarthritis Alleviation, and Functional Soft Chewable/Freeze-Dried Formulation Research. American Journal of Engineering Research (AJER), 15(8), 53-60.
- Kim, D. M., Lee, J. K., Lee, W. K., Kim, J. Y., Park, S. R., & Choi, Y. H. (2026). Purification of Saponin-PDRN Complex Derived from Platycodon grandiflorus Based on a Dual-Functional Magnetic Bead-Column System and Validation of its In Vitro / In Vivo Skin Regeneration, Barrier Enhancement, and WSSV Antiviral Efficacy. World Journal of Pharmaceutical Science and Research (WJPSR), 5(9), 77-87. https://doi.org/10.5281/zenodo.22159135
- Kim, D. M., Lee, J. K., Lee, W. K., Moon, H. A., Cho, Y. J., Bae, J. Y., Kim, J. W., & Choi, Y. M. (2026). Purification and Bioactivity Verification of Multi-purpose Plant-derived PDRN (Phyto-PDRN): A Study on Cell-Cultured Meat Media for Hoengseong Hanwoo (FBS Alternative), Skin Barrier Recovery, and Pet Kidney/Joint Protection. International Journal of Engineering, Management and Humanities (IJEMH), 7(5), 26-35. https://doi.org/10.5281/zenodo.22655282
- Kim, D. M., Lee, J. K., Lee, W. K., Moon, H. A., Cho, Y. J., Bae, J. Y., Kim, J. W., & Choi, Y. M. (2026). High-Efficiency Production and Biotechnological Applications of gamma-Oryzanol-Enriched Phyto-PDRN from Rice Bran Using an Eco-Friendly Reduced Pressure Extraction and Dual-Functional Affinity Bead Platform. IOSR Journal of Agriculture and Veterinary Science (IOSR-JAVS), 19(9), 31-38. https://doi.org/10.9790/2380-1909013138
- Kim, D. M., Lee, J. K., Lee, W. K., Moon, H. A., Cho, Y. J., Bae, J. Y., Kim, J. W., & Choi, Y. M. (2026). Comparative Study of Skin Bioactivity and Tissue Regeneration Efficacy of Phyto-PDRN Derived from Sea Grapes (Caulerpa lentillifera) and Conventional Extracts. International Journal of Advances in Engineering and Management (IJAEM), 8(10), 187-192. https://doi.org/10.5281/zenodo.23435011
- Kim, D. M., Lee, J. K., Lee, W. K., Kim, J. Y., Park, S. R., & Choi, Y. H. (2026). Efficacy of Winterberry (Rubus buergeri) Phyto-PDRN as a Non-Animal Alternative in Regenerative Therapies and Animal Supplements. International Journal of Engineering Inventions (IJEI), 15(10), 54-62. https://doi.org/10.5281/zenodo.23555038
- Kim, D. M., Kim, W. J., Lee, H. K., Kwon, Y. S., & Choi, Y. M. (2023). Efficacy in vitro Antioxidation and in vivo Skin Barrier Recovery of Composition Containing Mineral-cation-phyto DNA Extracted from Aloe vera Adventitious Root. Asian Journal of Beauty and Cosmetology, 21(2), 231-246. http://dx.doi.org/10.20402/ajbc.2023.0018
- Kim, D. M., Lee, J. K., Lee, W. K., Moon, H. A., Cho, Y. J., Bae, J. Y., Kim, J. W., & Choi, Y. M. (2026). Development and Preclinical Validation of a Houttuynia cordata-Derived Phyto-PDRN Ophthalmic Complex Formulation for Companion Animal Ocular Diseases. International Journal of Healthcare Sciences (IJHS), 14(2), 39-46. https://doi.org/10.5281/zenodo.23727447
- Kim, D. M., Jeong, J. Y., Lee, H. G., & Kwon, Y. S. (2020). Cosmetic composition for improving skin containing phyto-DNA extracted from Aloe vera adventitious roots. Korean Patent Publication No. 10-2021-0142296 (Application No. 10-2020-0058952, Patent Registration No. 10-2386801).
- Handong Co., Ltd. (2026). Method for preparing plant-derived PDRN complex containing ellagic acid and composition containing the same for protecting pet renal cells or alleviating patellar osteoarthritis. Korean Patent Application No. 10-2026-0188239.
- Baker, B. J., Heo, S. Y., Oh, G. W., Heo, S. J., & Jung, W. K. (2021). Applications of marine organism-derived polydeoxyribonucleotide: Its potential in biomedical engineering. Marine Drugs, 19(6), 296. https://doi.org/10.3390/md19060296
- Galeano, M., Bitto, A., Altavilla, D., Minutoli, L., Polito, F., Calo, M., Lo Cascio, P., Stagno d’Alcontres, F., & Squadrito, F. (2008). Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair and Regeneration, 16(2), 208-217. https://doi.org/10.1111/j.1524-475X.2008.00361.x
- Thellung, S., Florio, T., Maragliano, A., Cattarini, G., & Schettini, G. (1999). Polydeoxyribonucleotides enhance the proliferation of human skin fibroblasts: involvement of A2 purinergic receptor subtypes. Life Sciences, 64(18), 1661-1674. https://doi.org/10.1016/S0024-3205(99)00104-6
- United States Pharmacopeial Convention (2024). USP <51> Antimicrobial Effectiveness Testing & Ophthalmic Solutions. USP-NF.
- Zhang, R. J., Zhao, X., Xu, W., & Lee, S. (2021). Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven viral infection by hindering membrane fusion via lipid raft modulation. Experimental & Molecular Medicine, 53(5), 956-972. https://doi.org/10.1038/s12276-021-00634-1
- Korean Patent Registration No. 10-2707680 B1 (2024). Preparation method of high-purity plant-derived PDRN with excellent storage stability and composition for anti-inflammation, skin regeneration and wound healing containing the same.
- Kim, Y., & Lim, K. M. (2021). Skin barrier dysfunction and filaggrin. Archives of Pharmacal Research, 44, 36-48. https://doi.org/10.1007/s12272-021-01305-x
- Al-Kharusi, N., Babiker, F. A., & Al-Salam, S. (2022). Ellagic acid protects against cisplatin-induced nephrotoxicity in rats: A dose-dependent study. European Review for Medical and Pharmacological Sciences, 26, 299-310.
- Bylka, W., Znajdek-Awiżeń, P., Studzińska-Sroka, E., & Brzezińska, M. (2013). Centella asiatica in cosmetology. Postepy Dermatologii i Alergologii, 30(1), 46-49. https://doi.org/10.5114/pdia.2013.33378

